Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00896766 · ClinicalTrials.gov registry record

Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia

A clinical trial, sponsored by Children's Oncology Group.

Completed
Registry status
150
Enrollment target

NCT00896766 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00896766 has completed, sponsored by Children's Oncology Group.

COMPLETED
Registry status
150 participants
Enrollment target

Study Summary

RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at lymphoblasts in young patients with high-risk acute lymphoblastic leukemia.

Interventions

  • GENETIC microarray analysis
  • GENETIC polymorphism analysis
  • GENETIC tumor replication error analysis
  • GENETIC loss of heterozygosity analysis

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2006-05
Est. Completion 2016-05

Sponsor

Children's Oncology Group

342 total trials

What the Registry Record Tells You About NCT00896766

The ClinicalTrials.gov registry entry for NCT00896766 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which microarray analysis is the first listed.

NCT00896766 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00896766 about?

NCT00896766 is a clinical study titled "Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia". RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at lymphoblasts in young patie...

What is the current status of trial NCT00896766?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2006-05. Estimated completion is 2016-05.

What interventions are being tested in trial NCT00896766?

The interventions under investigation include: microarray analysis (GENETIC), polymorphism analysis (GENETIC), tumor replication error analysis (GENETIC), loss of heterozygosity analysis (GENETIC).

Who is sponsoring clinical trial NCT00896766?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.